Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Alibaba
BABA
|
+$812M |
| 2 |
AGN
Allergan plc
AGN
|
+$479M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$344M |
| 4 |
Apple
AAPL
|
+$312M |
| 5 |
Meta Platforms (Facebook)
META
|
+$264M |
Top Sells
| 1 |
RTX Corp
RTX
|
+$839M |
| 2 |
Qualcomm
QCOM
|
+$393M |
| 3 |
Las Vegas Sands
LVS
|
+$367M |
| 4 |
DISCA
Discovery, Inc. Series A Common Stock
DISCA
|
+$363M |
| 5 |
Perrigo
PRGO
|
+$359M |
Sector Composition
| 1 | Healthcare | 18.63% |
| 2 | Consumer Discretionary | 14.4% |
| 3 | Communication Services | 12.93% |
| 4 | Technology | 11.61% |
| 5 | Energy | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Sarepta Therapeutics
SRPT
$1.84B
| $21.6M | 0.02% |
+1,023,834
| New | +$21.6M |
|
|
CYT
427
DELISTED
CYTEC INDS INC
CYT
| $21.3M | 0.02% |
449,933
+31,505
| +8% | +$1.49M |
|
|
INFO
428
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $21.2M | 0.02% |
+908,671
| New | +$21.2M |
|
|
INXN
429
DELISTED
Interxion Holding N.V.
INXN
| $20.8M | 0.02% |
751,209
-488,961
| -39% | -$13.5M |
|
|
KIN
430
DELISTED
Kindred Biosciences, Inc.
KIN
| $20.7M | 0.02% |
2,232,725
+725,240
| +48% | +$6.71M |
|
|
CIM
431
Chimera Investment
CIM
$1.17B
| $20.4M | 0.02% |
446,934
-2,025
| -0.5% | -$92.3K |
|
|
DYAX
432
DELISTED
DYAX CORPORATION
DYAX
| $20.3M | 0.02% |
+2,010,562
| New | +$20.3M |
|
|
AGTC
433
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $20.2M | 0.02% |
1,084,520
+375,513
| +53% | +$6.99M |
|
434
Commault Systems
CVLT
$7.95B
| $19.9M | 0.02% |
394,932
+23,913
| +6% | +$1.21M |
|
|
MDCO
435
DELISTED
Medicines Co
MDCO
| $19.7M | 0.02% |
881,454
+1,317
| +0.1% | +$29.4K |
|
436
UnitedHealth
UNH
$312B
| $19.6M | 0.02% |
226,911
-425,576
| -65% | -$36.7M |
|
437
Sangamo Therapeutics
SGMO
$160M
| $19.1M | 0.02% |
1,768,392
-89,426
| -5% | -$964K |
|
|
HMHC
438
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $18.3M | 0.02% |
943,612
+60,807
| +7% | +$1.18M |
|
439
NN Inc
NNBR
$121M
| $18M | 0.02% |
672,281
+330,667
| +97% | +$8.84M |
|
440
Mercado Libre
MELI
$118B
| $17.9M | 0.02% |
+164,531
| New | +$17.9M |
|
|
LMOS
441
DELISTED
Lumos Networks Corp
LMOS
| $17.8M | 0.02% |
1,093,484
-342,643
| -24% | -$5.57M |
|
|
PKY
442
DELISTED
Parkway, Inc.
PKY
| $17.6M | 0.02% |
938,412
+130,164
| +16% | +$2.44M |
|
443
Prothena Corp
PRTA
$444M
| $17.5M | 0.02% |
790,179
-84,615
| -10% | -$1.88M |
|
|
PFPT
444
DELISTED
Proofpoint, Inc.
PFPT
| $17.1M | 0.02% |
460,022
+109,991
| +31% | +$4.09M |
|
445
Tandem Diabetes Care
TNDM
$839M
| $17.1M | 0.02% |
127,204
+5,268
| +4% | +$707K |
|
|
ORBC
446
DELISTED
ORBCOMM, Inc.
ORBC
| $16.4M | 0.02% |
2,843,639
+187,128
| +7% | +$1.08M |
|
447
Huron Consulting
HURN
$2.37B
| $16.3M | 0.02% |
267,419
-145,592
| -35% | -$8.88M |
|
|
PTLA
448
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $16.2M | 0.02% |
642,005
+959
| +0.1% | +$24.2K |
|
|
ALDR
449
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $16M | 0.01% |
1,262,087
+1,137,087
| +910% | +$14.4M |
|
|
CSII
450
DELISTED
Cardiovascular Systems, Inc.
CSII
| $16M | 0.01% |
675,670
+44,341
| +7% | +$1.05M |
|